Bernstein

Bernstein’s Toni Sacconaghi, Jr. expects Apple Inc. (NASDAQ: AAPL) to report relatively in-line results when it reports it FQ3 earnings on July 26. Sacconaghi maintained an Outperform rating on the company, while lowering the price target from $135 to $125. FQ3 Expectations The...

Chirantan Barua of Bernstein initiated coverage on two large-cap Swiss banks, UBS Group AG (USA) (NYSE: UBS) and Credit Suisse Group AG (ADR) (NYSE: CS) with Underweight ratings. Barua cited three fundamental concerns that fuel his bearish thesis. Quantitative Easing First, the quantitative easing...

  Pre-open movers U.S. stock futures traded higher in early pre-market trade. Data on nonfarm payrolls and unemployment rate for June will be released at 8:30 a.m. ET, while consumer credit report for May will be released at 3:00 p.m. ET. Futures for the Dow Jones Industrial Average...

The Wall Street Journal reported Thursday that Mark Crumpacker, Chipotle Mexican Grill, Inc. (NYSE: CMG)'s chief creative and development officer was charged with possession of cocaine. As a result, Chipotle placed Crumpacker on administrative leave and transferred the executive’s duties to...

Visa Inc (NYSE: V) shares closed 3 percent lower on July 30, while shares of Mastercard Inc (NYSE: MA) lost 4 percent, following news of the 2012 Merchant Litigation Settlement being overturned. Bernstein’s Lisa D. Ellis recommend in a report to “buy the weakness,” since the...

Bernstein has initiated coverage of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) with an Outperform rating and $400 price target, citing a "good entry point for one of stronger growers in biotech." "Regeneron is a growth-phase biopharma with one large successful first product (Eylea) and two...

Biogen Inc (NASDAQ: BIIB) has an aging MS franchise, but a solid biosimilar pipeline is sure to offset the loss of Tecfidera, Avonex and Tysabri. Bernstein's Aaron Gal initiated Biogen at outperform and set a price target of $282. The multiple sclerosis franchise has a five-year runway as...

Bernstein's Aaron Gal initiated Amgen, Inc. (NASDAQ: AMGN) at Market Perform and set a price target of $161. The company will have a hard time offsetting "stiff biosimilar headwinds," Gal noted. Amgen has a very old drug portfolio with G-CSFs, ESAs and Enbrel accounting for over 100 percent of its...

On Wednesday morning, Starbucks Corporation (NASDAQ: SBUX) shares spiked higher on no specific news. However, buried within various notes from sell-side analysts are some bullish charts highlighting pockets of strength for the coffee maker. To start, Bernstein has a note that shows the relative...

Bernstein said FedEx Corporation (NYSE: FDX) may be in for another transitional year following a mixed bag of results and outlook. The global package delivery company's fourth-quarter adjusted EPS and sales topped the Street's view as more consumers shopped online. But, the mid-point of its fiscal...

HP Inc (NYSE: HPQ) issued a surprise fiscal Q3 earnings announcement after the market close on Tuesday. The announcement included the sale of its marketing optimization assets, which will produce Q3 gains of $245 million and Q4 gains of $40 million for HP. In light of the sale, HP increased its Q3...

A substantial percentage of U.S. Prime users are using Amazon Prime Video, while a large number of them are also Netflix subscribers, Bernstein’s Carlos Kirjner said in a report. He added that in case a significant number of households were to choose an SVoD provider other than Amazon.com,...